The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hazen Samuel N since 2008.
This trader's CIK number is 1216838.
At the time of last reporting, Hazen Samuel N was the CEO of Hca Healthcare, Inc.. (stock ticker symbol HCA).
Also see all insider trading activities at Hca Healthcare, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HCA | 0 | $0 | 0 | $0 | 59,000 | $4,068,639 |
| 2022 | HCA | 0 | $0 | 0 | $0 | 6,011 | $0 |
| 2021 | HCA | 0 | $0 | 50,000 | $12,587,400 | 152,625 | $7,321,421 |
| 2020 | HCA | 0 | $0 | 121,875 | $16,556,962 | 557,125 | $13,472,396 |
| 2019 | HCA | 0 | $0 | 0 | $0 | 3,535 | $0 |
| 2018 | HCA | 0 | $0 | 56,000 | $5,626,208 | 428,192 | $7,529,847 |
| 2017 | HCA | 0 | $0 | 0 | $0 | 2,391 | $0 |
| 2015 | HCA | 0 | $0 | 180,000 | $14,400,000 | 360,000 | $2,993,040 |
| 2014 | HCA | 0 | $0 | 228,441 | $16,175,296 | 408,471 | $3,130,656 |
| 2012 | HCA | 0 | $0 | 0 | $0 | 179,902 | $509,122 |
| 2011 | HCA | 0 | $0 | 77,716 | $2,247,002 | 86,306 | $244,245 |
| 2010 | HCA | 0 | $0 | 0 | $0 | 19,163 | $244,328 |
| 2008 | HCA | 0 | $0 | 0 | $0 | 28,123 | $358,568 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-03 | HCA | Option Ex | 59,000 | 68.96 | 4,068,639 |
| 2022-02-18 | HCA | Option Ex | 6,011 | .00 | 0 |
| 2021-11-02 | HCA | Sale | 50,000 | 251.75 | 12,587,400 |
| 2021-10-29 | HCA | Option Ex | 152,625 | 47.97 | 7,321,421 |
| 2020-11-03 | HCA | Option Ex | 557,125 | 24.18 | 13,472,396 |
| 2020-11-03 | HCA | Sale | 121,875 | 135.85 | 16,556,962 |
| 2019-02-25 | HCA | Option Ex | 3,535 | .00 | 0 |
| 2018-02-25 | HCA | Option Ex | 5,926 | .00 | 0 |
| 2018-01-31 | HCA | Option Ex | 422,266 | 17.83 | 7,529,847 |
| 2018-01-31 | HCA | Sale | 56,000 | 100.47 | 5,626,208 |
| 2017-02-25 | HCA | Option Ex | 2,391 | .00 | 0 |
| 2015-04-15 | HCA | Option Ex | 360,000 | 8.31 | 2,993,040 |
| 2015-04-15 | HCA | Sale | 180,000 | 80.00 | 14,400,000 |
| 2014-12-23 | HCA | Option Ex | 360,081 | 8.31 | 2,993,713 |
| 2014-12-23 | HCA | Sale | 180,051 | 75.00 | 13,503,825 |
| 2014-08-04 | HCA | Sale | 19,374 | 66.00 | 1,278,703 |
| 2014-08-04 | HCA | Option Ex | 19,374 | 2.83 | 54,828 |
| 2014-02-07 | HCA | Sale | 29,016 | 48.00 | 1,392,768 |
| 2014-02-07 | HCA | Option Ex | 29,016 | 2.83 | 82,115 |
| 2012-11-05 | HCA | Option Ex | 179,902 | 2.83 | 509,122 |
| 2011-11-02 | HCA | Option Ex | 86,306 | 2.83 | 244,245 |
| 2011-03-15 | HCA | Sale | 77,716 | 28.91 | 2,247,002 |
| 2010-12-10 | NONE | Option Ex | 19,163 | 12.75 | 244,328 |
| 2008-12-17 | NONE | Option Ex | 28,123 | 12.75 | 358,568 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hazen Samuel N (CEO of Hca Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.